A novel approach for studying mast cell–driven disorders: Mast cells derived from induced pluripotent stem cells
Authors:
- Pavel KolkhirPKPavel Kolkhir
- Marcus MaurerMMMarcus Maurer
- Jörg ScheffelJSJörg Scheffel
- 1 March 2022
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 149 (3) , 1060-1068.e4
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Human mast cells arise from a common circulating progenitorJournal of Allergy and Clinical Immunology, 2013
- IgE and mast cells in allergic diseaseNature Medicine, 2012
- Disease-specific induced pluripotent stem cells: a platform for human disease modeling and drug discoveryExperimental & Molecular Medicine, 2012
- Characterization of a novel human mast cell line that responds to stem cell factor and expresses functional FcεRIJournal of Allergy and Clinical Immunology, 2011
- Mast cell lines HMC‐1 and LAD2 in comparison with mature human skin mast cells – drastically reduced levels of tryptase and chymase in mast cell linesExperimental Dermatology, 2010
- Human embryonic stem cells: a source of mast cells for the study of allergic and inflammatory diseasesBlood, 2010
- Seven week culture of functional human mast cells from buffy coat preparationsJournal of Immunological Methods, 2008
- MAST CELLS AS “TUNABLE” EFFECTOR AND IMMUNOREGULATORY CELLS: Recent AdvancesAnnual Review of Immunology, 2005
- Human basophil/mast cell releasability. XI. Heterogeneity of the effects of contrast media on mediator releaseJournal of Allergy and Clinical Immunology, 1996
- Ultrastructural and Immunohistochemical Characterization of Normal Mast Cells at Multiple Body SitesJournal of Investigative Dermatology, 1991